Prostate Cancer / Advances in Experimental Medicine and Biology Bd.1210 (PDF)

Name: Prostate Cancer / Advances in Experimental Medicine and Biology Bd.1210
Brand: Springer-Verlag GmbH
SKU: 133868629
Price: 229.90 EUR
Availability: OnlineOnly

Cellular and Genetic Mechanisms of Disease Development and Progression (Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Prostate Cancer / Advances in Experimental Medicine and Biology Bd.1210".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 229.90 €

Buch (Gebunden) 241.99 €

sofort als Download lieferbar

Bestellnummer: 133868629

Printausgabe 241.99 €

eBook (pdf) -5% 229.90 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Prostate Cancer / Advances in Experimental Medicine and Biology Bd.1210 (PDF)“

The purpose of this book is to provide a contemporary overview of the causes and consequences of prostate cancer from a cellular and genetic perspective. Written by experts in the fields of epidemiology, toxicology, cell biology, genetics, genomics, cell-cell interactions, cell signaling, hormone signaling, and transcriptional regulation, the text covers aspects of prostate cancer from disease initiation to metastasis.

Chapters explore in depth the cells of origin for prostate cancer, its genomic subtypes, neural transcription factors in disease progression, epigenetic regulation of chromatin, and many other topics. This book distinguishes itself from other texts on prostate cancer by its focus on cellular and genetic mechanisms, as opposed to clinical diagnosis and management. As a result, this book will be of broad interest to basic and translational scientists with familiarity of these topics, as well as to trainees at earlier stages of their research careers.

Autoren-Porträt

Scott Dehm is Professor in the Departments of Laboratory Medicine and Pathology and Urology at University of Minnesota. He holds the Apogee Enterprises Chair of Cancer Research at the Masonic Cancer Center, University of Minnesota. He obtained his Ph.D. degree in Biochemistry from the University of Saskatchewan.

Donald Tindall is Professor Emeritus in the Departments of Biochemistry and Molecular Biology and Urology at Mayo Clinic. He obtained his Ph.D. degree from the University of North Carolina at Chapel Hill.